Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Collegium Pharmaceutical Inc COLL

Collegium Pharmaceutical, Inc. is a diversified specialty pharmaceutical company. The Company commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta ER and Nucynta immediate-release (IR), Belbuca, and Symproic in the United States. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is a pain treatment option designed... see more

Recent & Breaking News (NDAQ:COLL)

Collegium to Present at Upcoming Investor Conferences

GlobeNewswire September 6, 2017

Collegium Announces Scientific Presentations at PAINWeek 2017 Meeting

GlobeNewswire September 5, 2017

Daily Technical Summary Reports on Generic Drugs Stocks -- Collegium Pharma, Momenta Pharma, Lipocine, and Diplomat Pharma

PR Newswire August 23, 2017

Collegium Reports Second Quarter Financial Results and Provides Corporate Update

GlobeNewswire August 9, 2017

Investor Network: Collegium Pharmaceutical, Inc. to Host Earnings Call

ACCESS Newswire August 9, 2017

Collegium to Host Conference Call to Discuss Second Quarter 2017 Financial Results and Provide Corporate Update

GlobeNewswire July 18, 2017

Generic Drugs Stocks on Investors' Radar -- Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharma

PR Newswire June 28, 2017

Collegium Announces Scientific Presentations at the 2017 International Conference on Opioids

GlobeNewswire June 8, 2017

Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medicare Part D Patients

GlobeNewswire June 1, 2017

Collegium Announces the Appointment of Joseph Ciaffoni as Chief Operating Officer

GlobeNewswire May 30, 2017

Collegium to Present at Upcoming Investor Conferences

GlobeNewswire May 23, 2017

How These Generic Drugs Stocks are Faring? -- Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharmacy

PR Newswire May 15, 2017

Collegium Reports First Quarter Financial Results and Provides Corporate Update

GlobeNewswire May 10, 2017

Investor Network: Collegium Pharmaceutical, Inc. to Host Earnings Call

ACCESS Newswire May 10, 2017

Collegium to Host Conference Call to Discuss First Quarter 2017 Financial Results and Provide Corporate Update

GlobeNewswire May 3, 2017

Collegium to Present at the 42nd Annual Deutsche Bank Healthcare Conference

GlobeNewswire April 20, 2017

Collegium Announces Appointment of Steven Passik, PhD, as Vice President, Scientific Affairs, Education and Policy

GlobeNewswire April 4, 2017

Collegium Announces Expanded Managed Care Coverage for Xtampza ER for Medicare Part D Patients

GlobeNewswire April 3, 2017

Collegium to Present at the 16th Annual Needham Healthcare Conference

GlobeNewswire March 28, 2017

Collegium Announces Scientific Presentation at American Academy of Pain Medicine 2017 Meeting

GlobeNewswire March 16, 2017